Trending...
- Roofman USA Expands Roofing Services Across Michigan, Adding Key Locations - 173
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025 - 160
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience - 151
VALFIX Medical is developing a trans-catheter solution for patients suffering from valvular heart disease and heart failure.
DOVER, Del. - Michimich -- VALFIX Medical Inc. announces the issuance of a new patent by its Israeli subsidiary VALFIX Medical Ltd. The new Patent US 11,931,021 B2 is titled "Anchors and locks for percutaneous valve implants".
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on Michimich.com
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
The granted patent outlines multiple locking mechanisms that secure an implant to its target location by applying gripping forces on a surgical suture that passes through the implant.
"It is exciting to receive the new patents as we continue to push the technology forward; our approach to valve repair remains unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. "This patent granted confirms and protects our core technology and adds significant value to our stakeholders."
More on Michimich.com
- New Leadership and Renovations Usher in Next Chapter for Sunrise Manor
- Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections
- Geeks5g Creative Marketing: The Powerhouse Behind Business Growth
- Two new inductees selected to the Trenton Educational Foundation's Wall of Fame
- Agemin Unveils Breakthrough AI Model for Biometric Age Estimation, Setting New Standards in Online Child Safety
VALFIX Medical technology is distinguished in its approach to offer valve repair method that truly replicate the surgical annuloplasty approach. Using specially designed anchors and locks VALFIX achieve unparalleled operational flexibility, anatomic precision, and implant stability.
This unique approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
About VALFIX Medical:
VALFIX has developed an innovative transcatheter system to treat heart failure patients suffering from significant functional mitral valve regurgitation (FMR). VALFIX's unique and innovative transcatheter technology offers a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or
contact us directly at info@valfixmed.com
Source: Valfix medical Inc.
Filed Under: Health
0 Comments
Latest on Michimich.com
- Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
- IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
- Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
- NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
- Broadway Gala Honored Also an Italian
- $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
- AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
- CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
- Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
- Local consultant shows small businesses how to turn red tape into real money
- Nora Knople Honored as a Leader and Innovator in Hypnosis
- Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
- Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
- Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
- Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
- Comerica Incorporated Names Kristina Janssens Senior Executive Vice President and Chief Risk Officer
- ENTOUCH Completes $50 million Funding Round
- Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
- Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
- From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™